medroxyprogesterone acetate has been researched along with Hyperlipemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, S; Kumakura, H; Kurabayashi, M; Sakamaki, T; Sakamoto, H; Sawada, Y; Sumino, H; Takayama, Y | 1 |
| Mortensen, A; Nielsen, LB; Nilas, L; Ottesen, B; Pedersen, SH; Sheykhzade, M | 1 |
1 trial(s) available for medroxyprogesterone acetate and Hyperlipemia
| Article | Year |
|---|---|
Effects of conjugated equine estrogen and medroxyprogesterone acetate on lipoprotein(a) and other lipoproteins in japanese postmenopausal women with and without dyslipidemia.
Topics: Asian People; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hyperlipidemias; Lipoprotein(a); Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Triglycerides | 2004 |
1 other study(ies) available for medroxyprogesterone acetate and Hyperlipemia
| Article | Year |
|---|---|
Medroxyprogesterone acetate attenuates long-term effects of 17beta-estradiol in coronary arteries from hyperlipidemic rabbits.
Topics: Animals; Base Sequence; Cholesterol; Coronary Vessels; Estradiol; Estrogen Replacement Therapy; Female; Hyperlipidemias; Medroxyprogesterone Acetate; Molecular Sequence Data; Organ Size; Ovariectomy; Rabbits; Time Factors | 2006 |